Louisiana Enacts Commercial PBM Reimbursement Floor Using NADAC
Louisiana enacted Act 913 on June 12, establishing a commercial market reimbursement floor for pharmacy benefit managers that requires use of National Average Drug Acquisition Cost (NADAC) as the reimbursement benchmark. The law applies to commercial PBM arrangements and includes provisions intended to prevent cost-shifting to patients. The legislation took effect upon signing and affects how PBMs reimburse pharmacies in commercial insurance markets in Louisiana.
Louisiana's commercial PBM reform establishes precedent that may influence future Medicaid managed care pharmacy reimbursement policy in the state, as NADAC is already the federal benchmark for Medicaid fee-for-service pharmacy reimbursement.
Pharmacy
You might also like